Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENFORCE
NCT04833426Phase 3Recruiting
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Dec 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Testosterone TEPI patch in testosterone deficiency (TD), sponsored by Canisius-Wilhelmina Hospital. Started Dec 2022; status: recruiting.
02
Drugs
Testosterone TEPI patch
03
Conditions
testosterone deficiency (TD)
Beyond the preview
Go deeper on NCT04833426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833426.